MedTrace Logo

Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

NCT07803185 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-09-03

No results posted yet for this study

Summary

This prospective observational study evaluates the longitudinal changes in anhedonia levels and emotional eating behaviors among adult individuals initiating glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss. Participants are assessed at baseline (treatment initiation) and after a 6-month follow-up period using standardized psychometric instruments.

Conditions

  • Obesity
  • Emotional Eating
  • Anhedonia

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07803185 on ClinicalTrials.gov